900000000000489007: Concept inactivation indicator attribute value reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Attribute value type\Concept inactivation indicator reference set

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Concept inactivation indicator reference set	Is a	Attribute value type	true	Inferred relationship	Some

Members	valueId
Advanced directive signed	Ambiguous
Advancement of eye muscle	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Advancement of eyelid muscle	Ambiguous
Advancement of flap graft	A component that is no longer current, useful, appropriate or acceptable.
Advancement of mucosa of lip NEC	Classification derived component
Advancement of pedicle graft	Ambiguous
Adventitial dissecting aneurysm	Ambiguous
Advera	Moved elsewhere
Adverse cutaneous reaction caused by aromatherapy	Ambiguous
Adverse cutaneous reaction caused by chinese traditional herbal medicine	Ambiguous
Adverse drug event resulting from treatment of disorder	Ambiguous
Adverse drug reaction notif	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse drug reaction resulting from treatment of disorder	Ambiguous
Adverse effect of correct biological substance after proper administration	Ambiguous
Adverse effect of oral diphosphonate	Erroneous component (foundation metadata concept)
Adverse effect of physical agent	Ambiguous
Adverse effect of radiation therapy	Ambiguous
Adverse effect, caused by correct medicinal substance properly administered	Ambiguous
Adverse effects NEC	Classification derived component
Adverse effects NOS	Classification derived component
Adverse event following complementary therapy	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse event following complementary therapy	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse health risk due to absence of sink in residence	Erroneous component (foundation metadata concept)
Adverse health risk due to absence of toilet in residence	Erroneous component (foundation metadata concept)
Adverse health risk due to asbestos in residence	Erroneous component (foundation metadata concept)
Adverse health risk due to carbon monoxide in residence	Erroneous component (foundation metadata concept)
Adverse health risk due to infestation of residence	Erroneous component (foundation metadata concept)
Adverse health risk due to lack of equipment for safe food storage in residence	Erroneous component (foundation metadata concept)
Adverse health risk due to lack of food preparation equipment in residence	Erroneous component (foundation metadata concept)
Adverse health risk due to lead in residence	Erroneous component (foundation metadata concept)
Adverse health risk due to mold in residence	Erroneous component (foundation metadata concept)
Adverse health risk due to radon in residence	Erroneous component (foundation metadata concept)
Adverse reaction caused by acidifying agent	A component that fails to comply with the current editorial guidance.
Adverse reaction caused by adrenochrome derivative	Ambiguous
Adverse reaction caused by alkalizing agents	A component that fails to comply with the current editorial guidance.
Adverse reaction caused by analgesics, antipyretics and antirheumatics	Ambiguous
Adverse reaction caused by anti-common cold drug	Ambiguous
Adverse reaction caused by anti-infective lead compound	Ambiguous
Adverse reaction caused by antidiabetic drug	Ambiguous
Adverse reaction caused by antiplatelet agent	Ambiguous
Adverse reaction caused by aromatic analgesic	Ambiguous
Adverse reaction caused by arsenical anti-infective	Ambiguous
Adverse reaction caused by bismuth anti-infective compound	Ambiguous
Adverse reaction caused by bromide	Ambiguous
Adverse reaction caused by carbromal derivative	Erroneous component (foundation metadata concept)
Adverse reaction caused by diphosphonate	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction caused by drug acting on bone metabolism	Ambiguous
Adverse reaction caused by drug or medicament administered by infusion	Ambiguous
Adverse reaction caused by drug primarily acting on the smooth and skeletal muscles and respiratory system	A component that fails to comply with the current editorial guidance.
Adverse reaction caused by drugs primarily acting on the smooth or skeletal muscles or respiratory system	Ambiguous
Adverse reaction caused by eye drug	Ambiguous
Adverse reaction caused by figs compound laxative	A component that fails to comply with the current editorial guidance.
Adverse reaction caused by glutethimide group	Ambiguous
Adverse reaction caused by hydantoin derivative	Ambiguous
Adverse reaction caused by hypnotic AND/OR sedative	Ambiguous
Adverse reaction caused by hypothalamic/pituitary hormone	A component that fails to comply with the current editorial guidance.
Adverse reaction caused by intravenous diphosphonate	Erroneous component (foundation metadata concept)
Adverse reaction caused by liver preparations and other antianemic agents	A component that fails to comply with the current editorial guidance.
Adverse reaction caused by methaqualone compound	Ambiguous
Adverse reaction caused by mixed bacterial vaccine	Ambiguous
Adverse reaction caused by ovarian hormone	Ambiguous
Adverse reaction caused by over the counter drug	Ambiguous
Adverse reaction caused by parasympatholytic and spasmolytic	Ambiguous
Adverse reaction caused by pipazethate hydrochloride	Ambiguous
Adverse reaction caused by primarily systemic agents	Ambiguous
Adverse reaction caused by substance	A component that fails to comply with the current editorial guidance.
Adverse reaction caused by sympatholytic	Ambiguous
Adverse reaction caused by typhoid and paratyphoid vaccines	Ambiguous
Adverse reaction caused by vaccine properly administered	Ambiguous
Adverse reaction following injection of neurotoxin	Ambiguous
Adverse reaction to BCG vaccine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to CNS depressants and anesthetics	A component that fails to comply with the current editorial guidance.
Adverse reaction to H2 blockers	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to acebutolol	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to acetazolamide	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to acetohexamide	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to acetylcholine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to acetylcysteine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to actinomycin D	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to acyclovir	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to adrenal cortical steroid	Ambiguous
Adverse reaction to adrenal cortical steroid NOS	Limited component (foundation metadata concept)
Adverse reaction to adrenaline, epinephrine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to agent affecting blood constituents NOS	Classification derived component
Adverse reaction to agent affecting blood constituents NOS	Classification derived component
Adverse reaction to agents primarily affecting blood constituents	A component that fails to comply with the current editorial guidance.
Adverse reaction to agents primarily affecting blood constituents	A component that fails to comply with the current editorial guidance.
Adverse reaction to alcohol	Ambiguous
Adverse reaction to alcohol deterrents	Ambiguous
Adverse reaction to alcuronium	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to allopurinol	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to allylestrenol	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to aluminum hydroxide	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to amantadine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to amikacin	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to amiloride	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to aminophylline	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to amitriptyline	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to amoxycillin	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to amphotericin	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to ampicillin	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.

Start Previous Page 75 of 1411 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001066017	Concept inactivation indicator attribute value reference set	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001067014	Concept inactivation indicator reference set	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001068016	Concept inactivation indicator attribute value reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)